Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Transplantation ; 71(11): 1622-30, 2001 Jun 15.
Artigo em Inglês | MEDLINE | ID: mdl-11435975

RESUMO

BACKGROUND: We have previously demonstrated that human artery grafts transplanted to immunodeficient mice are infiltrated and injured by unsensitized allogeneic human T cells. We extended our investigations to human anti-porcine xenoresponses in this model. METHODS: Pig coronary artery segments were interposed into the infrarenal aorta of severe combined immunodeficiency/beige mice. After 7 days, certain recipients were reconstituted with human leukocytes and/or treated with proinflammatory cytokines. The grafts were harvested after 1-70 days and examined by histology, immunohistochemistry, and morphometry. RESULTS: Pig artery grafts from untreated mice had no evidence of injury, leukocytic infiltrate, or endothelial cell activation up to 70 days postoperatively, despite deposition of murine complement. Host reconstitution with human peripheral blood mononuclear cells resulted in a discrete population of circulating T cells that did not infiltrate or injure the grafts up to 28 days after adoptive transfer. Administration of porcine interferon-gamma for up to 28 days sustained the expression of graft vascular cell adhesion molecule-1 and major histocompatibility complex antigens, but did not initiate recruitment of human leukocytes. In contrast, treatment with human tumor necrosis factor for 7 days induced the de novo expression of porcine E-selectin by graft endothelial cells and elicited human T cell infiltration and human peripheral blood mononuclear cell-dependent vascular injury. CONCLUSIONS: The human peripheral blood mononuclear cell-severe combined immunodeficiency/beige mouse model identifies a significant difference between human T cell allogeneic and xenogeneic responses in vivo. Xenografts with quiescent endothelium are not infiltrated or injured by T cells under the same conditions in which allografts are rejected. Activation of pig coronary artery endothelial cells by human tumor necrosis factor, but not porcine interferon-gamma, elicits cellular xenoresponses.


Assuntos
Vasos Coronários/transplante , Endotélio Vascular/fisiologia , Endotélio Vascular/transplante , Imunodeficiência Combinada Severa/cirurgia , Animais , Artérias/efeitos dos fármacos , Artérias/patologia , Artérias/transplante , Células Sanguíneas/patologia , Vasos Coronários/efeitos dos fármacos , Vasos Coronários/patologia , Rejeição de Enxerto/induzido quimicamente , Humanos , Tolerância Imunológica , Interferon gama/farmacologia , Camundongos , Camundongos SCID , Imunodeficiência Combinada Severa/sangue , Suínos , Linfócitos T/efeitos dos fármacos , Linfócitos T/patologia , Imunologia de Transplantes , Fator de Necrose Tumoral alfa/farmacologia
3.
Am J Cardiol ; 86(11): 1261-4, A6, 2000 Dec 01.
Artigo em Inglês | MEDLINE | ID: mdl-11090805

RESUMO

After coronary artery bypass grafting, our patients with ischemic cardiomyopathy and significant left ventricular (LV) dilation demonstrated an improvement in angina symptoms, acceptable operative and medium-term survival, a trend toward improvement in LV ejection fraction, and a significant reduction in LV chamber size. Our results suggest that patients with ischemic cardiomyopathy and LV dilation should not be excluded from surgical revascularization based on ventricular size alone.


Assuntos
Volume Cardíaco/fisiologia , Ponte de Artéria Coronária , Ventrículos do Coração , Isquemia Miocárdica/fisiopatologia , Função Ventricular Esquerda/fisiologia , Idoso , Idoso de 80 Anos ou mais , Ecocardiografia , Feminino , Imagem do Acúmulo Cardíaco de Comporta , Ventrículos do Coração/diagnóstico por imagem , Humanos , Masculino , Pessoa de Meia-Idade , Contração Miocárdica/fisiologia , Isquemia Miocárdica/diagnóstico , Isquemia Miocárdica/cirurgia , Radiografia , Estudos Retrospectivos , Resultado do Tratamento
4.
J Immunol ; 164(12): 6601-9, 2000 Jun 15.
Artigo em Inglês | MEDLINE | ID: mdl-10843720

RESUMO

TNF activates endothelial cells to express cell surface molecules that are necessary to recruit a local infiltrate of leukocytes. Because the actions of this proinflammatory cytokine are not species restricted, we investigated whether human TNF can up-regulate porcine endothelial adhesion molecules to elicit human T cell infiltration and damage of pig skin xenografts in a chimeric immunodeficient mouse model. We have previously demonstrated the vigorous rejection of human skin allografts and the absence of injury to porcine skin xenografts in human PBMC-SCID/beige mice. Intradermal administration of human TNF at high doses (600 or 2000 ng) caused nonspecific inflammatory damage of pig skin grafts, whereas low concentrations of TNF (60 or 200 ng) resulted in human PBMC-dependent injury of porcine endothelial cells. There was a strong correlation among pig skin xenograft damage, human T cell infiltration, and the TNF-induced up-regulation of swine MHC class I and class II molecules, VCAM-1, and, in particular, the de novo expression of porcine E-selectin. The microvascular damage and leukocytic infiltration elicited by TNF were enhanced by porcine IFN-gamma, suggesting that xenografts may be less prone to cytokine-mediated injury due to the species-restricted effects of recipient IFN-gamma. Our results indicate that maintenance of a quiescent endothelium, which does not express E-selectin or other activation-dependent adhesion molecules, is important in preventing human anti-porcine T cell xenoresponses in vivo and that TNF signaling molecules and TNF-responsive gene products are appropriate therapeutic targets to protect against human T cell-mediated rejection of pig xenografts.


Assuntos
Imunodeficiência Combinada Severa/imunologia , Imunodeficiência Combinada Severa/patologia , Transplante de Pele/imunologia , Transplante de Pele/patologia , Transplante Heterólogo , Fator de Necrose Tumoral alfa/toxicidade , Transferência Adotiva , Adulto , Animais , Moléculas de Adesão Celular/biossíntese , Relação Dose-Resposta Imunológica , Sinergismo Farmacológico , Endotélio Vascular/imunologia , Endotélio Vascular/metabolismo , Endotélio Vascular/patologia , Rejeição de Enxerto/genética , Rejeição de Enxerto/imunologia , Rejeição de Enxerto/patologia , Rejeição de Enxerto/fisiopatologia , Antígenos de Histocompatibilidade/biossíntese , Humanos , Interferon gama/toxicidade , Camundongos , Camundongos Endogâmicos C57BL , Camundongos SCID , Microcirculação/imunologia , Microcirculação/patologia , Imunodeficiência Combinada Severa/genética , Imunodeficiência Combinada Severa/fisiopatologia , Transplante de Pele/efeitos adversos , Suínos , Linfócitos T/transplante , Transplante Heterólogo/efeitos adversos , Regulação para Cima/imunologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA